Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection.

BACKGROUND 5-Aminolevulinic acid (5-ALA)-induced tumor fluorescence aids brain tumor resections but is not approved for routine use in the United States. We developed and describe testing of 2 novel fluorescent, cancer-selective alkylphosphocholine analogs, CLR1501 (green) and CLR1502 (near infrared), in a proof-of-principle study for fluorescence-guided glioma surgery. OBJECTIVE To demonstrate that CLR1501 and CLR1502 are cancer cell-selective fluorescence agents in glioblastoma models and to compare tumor-to-normal brain (T:N) fluorescence ratios with 5-ALA. METHODS CLR1501, CLR1502, and 5-ALA were administered to mice with magnetic resonance imaging-verified orthotopic U251 glioblastoma multiforme- and glioblastoma stem cell-derived xenografts. Harvested brains were imaged with confocal microscopy (CLR1501), the IVIS Spectrum imaging system (CLR1501, CLR1502, and 5-ALA), or the Fluobeam near-infrared fluorescence imaging system (CLR1502). Imaging and quantitative analysis of T:N fluorescence ratios were performed. RESULTS Excitation/emission peaks are 500/517 nm for CLR1501 and 760/778 nm for CLR1502. The observed T:N ratio for CLR1502 (9.28±1.08) was significantly higher (P<.01) than for CLR1501 (3.51±0.44 on confocal imaging; 7.23±1.63 on IVIS imaging) and 5-ALA (4.81±0.92). Near-infrared Fluobeam CLR1502 imaging in a mouse xenograft model demonstrated high- contrast tumor visualization compatible with surgical applications. CONCLUSION CLR1501 (green) and CLR1502 (near infrared) are novel tumor-selective fluorescent agents for discriminating tumor from normal brain. CLR1501 exhibits a tumor-to-brain fluorescence ratio similar to that of 5-ALA, whereas CLR1502 has a superior tumor-to-brain fluorescence ratio. This study demonstrates the potential use of CLR1501 and CLR1502 in fluorescence-guided tumor surgery.

[1]  G von Campe,et al.  5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. , 2008, Swiss medical weekly.

[2]  Keith D. Paulsen,et al.  δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. , 2011, Neuro-oncology.

[3]  R. Díez Valle,et al.  Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience , 2011, Journal of neuro-oncology.

[4]  W. Stummer,et al.  In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. , 1998, Journal of photochemistry and photobiology. B, Biology.

[5]  Xiaoyao Fan,et al.  Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. , 2011, Journal of neurosurgery.

[6]  D. Garbossa,et al.  Fluorescence and image guided resection in high grade glioma , 2012, Clinical Neurology and Neurosurgery.

[7]  Summer L. Gibbs,et al.  Near infrared fluorescence for image-guided surgery. , 2012, Quantitative imaging in medicine and surgery.

[8]  M. Kéramidas,et al.  Intraoperative near‐infrared image‐guided surgery for peritoneal carcinomatosis in a preclinical experimental model , 2010, The British journal of surgery.

[9]  Keith D. Paulsen,et al.  Quantitative, spectrally-resolved intraoperative fluorescence imaging , 2012, Scientific Reports.

[10]  P. Low,et al.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.

[11]  H Stepp,et al.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.

[12]  Henry Brem,et al.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.

[13]  Andreas Raabe,et al.  Prospective evaluation of surgical microscope-integrated intraoperative near-infrared indocyanine green videoangiography during aneurysm surgery. , 2005, Journal of neurosurgery.

[14]  M. Shepherd,et al.  A continuous fluorimetric assay for protoporphyrinogen oxidase by monitoring porphyrin accumulation. , 2005, Analytical biochemistry.

[15]  Mitchel S Berger,et al.  An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.

[16]  N. Sanai,et al.  Trends in fluorescence image-guided surgery for gliomas. , 2014, Neurosurgery.

[17]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[18]  Jennifer Eschbacher,et al.  Miniaturized Handheld Confocal Microscopy for Neurosurgery: Results in an Experimental Glioblastoma Model , 2010, Neurosurgery.

[19]  Xiaoyao Fan,et al.  Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. , 2011, Journal of neurosurgery.

[20]  M. Huizing,et al.  Retro-orbital injections in mice , 2011, Lab Animal.

[21]  A. Alavi,et al.  Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies , 2007, Nuclear medicine communications.

[22]  Confocal neurolasermicroscopy in human brain - perspectives for neurosurgery on a cellular level (including additional comments to this article). , 2010, Central European neurosurgery.

[23]  H Stepp,et al.  Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.

[24]  Jean-Luc Coll,et al.  Near-infrared optical guided surgery of highly infiltrative fibrosarcomas in cats using an anti-αvß3 integrin molecular probe. , 2013, Cancer letters.

[25]  M. Golzio,et al.  Intraoperative fluorescence imaging of peritoneal dissemination of ovarian carcinomas. A preclinical study. , 2011, Gynecologic oncology.

[26]  W. Stummer,et al.  Technical Principles for Protoporphyrin-IX-Fluorescence Guided Microsurgical Resection of Malignant Glioma Tissue , 1998, Acta Neurochirurgica.

[27]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[28]  J. Frangioni,et al.  Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation , 2010, Molecular imaging.

[29]  J. Kuo,et al.  Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. , 2012, Neoplasia.

[30]  T. Shuin,et al.  Comparison between intravesical and oral administration of 5‐aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer , 2012, Cancer.

[31]  Peter Nakaji,et al.  Use of in vivo near-infrared laser confocal endomicroscopy with indocyanine green to detect the boundary of infiltrative tumor. , 2011, Journal of neurosurgery.

[32]  Jennifer Eschbacher,et al.  Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. , 2011, Journal of neurosurgery.

[33]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[34]  Arya Nabavi,et al.  FIVE‐AMINOLEVULINIC ACID FOR FLUORESCENCE‐GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS: A PHASE II STUDY , 2009, Neurosurgery.

[35]  F. DiMeco,et al.  Erratum: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma (Cancer Research (October 2004) 64 (7011-7021) , 2004 .

[36]  Steve Y. Cho,et al.  A Phase 1 Study of 131I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety , 2014, PloS one.

[37]  S. Coons,et al.  Intraoperative Confocal Microscopy for Brain Tumors: A Feasibility Analysis in Humans , 2011, Neurosurgery.

[38]  J. Kuo,et al.  Differential Expression of 2′,3′-Cyclic-Nucleotide 3′-Phosphodiesterase and Neural Lineage Markers Correlate with Glioblastoma Xenograft Infiltration and Patient Survival , 2012, Clinical Cancer Research.

[39]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[40]  S. Coons,et al.  In vivo intraoperative confocal microscopy for real-time histopathological imaging of brain tumors. , 2012, Journal of neurosurgery.

[41]  P. Pickhardt,et al.  Alkylphosphocholine Analogs for Broad-Spectrum Cancer Imaging and Therapy , 2014, Science Translational Medicine.

[42]  Mamta Khurana,et al.  Quantification of in vivo fluorescence decoupled from the effects of tissue optical properties using fiber-optic spectroscopy measurements. , 2010, Journal of biomedical optics.

[43]  Pieter L Kubben,et al.  Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. , 2011, The Lancet. Oncology.